133 related articles for article (PubMed ID: 1663576)
21. Retinal toxicity and ocular kinetics of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in rabbits.
Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Tanahashi T; Ijichi K; Machida H
Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):503-8. PubMed ID: 7926887
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication.
Lin JC; Reefschläger J; Herrmann G; Pagano JS
Antiviral Res; 1992 Jan; 17(1):43-52. PubMed ID: 1310582
[TBL] [Abstract][Full Text] [Related]
23. Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.
Soike K; Huang JL; Tu JI; Stouffer B; Mitroka JG; Swerdel M; Olsen S; Bonner DP; Tuomari AV; Field AK
J Infect Dis; 1992 Apr; 165(4):732-6. PubMed ID: 1313071
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S
Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364
[TBL] [Abstract][Full Text] [Related]
25. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
Machida H; Nishitani M; Ashida N
Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication.
Lin JC; Machida H
Antimicrob Agents Chemother; 1988 Jul; 32(7):1068-72. PubMed ID: 2847639
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
[TBL] [Abstract][Full Text] [Related]
28. In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil.
Machida H; Sakata S; Kuninaka A; Yoshino H; Nakayama C; Saneyoshi M
Antimicrob Agents Chemother; 1979 Aug; 16(2):158-63. PubMed ID: 485126
[TBL] [Abstract][Full Text] [Related]
29. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of 5'-ether prodrugs of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in rats.
Ashida N; Ijichi K; Watanabe Y; Machida H
Biochem Pharmacol; 1993 Dec; 46(12):2201-7. PubMed ID: 8274153
[TBL] [Abstract][Full Text] [Related]
31. A radioimmunoassay for the new antiviral agent 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Jagoda E; Ogan M; Stouffer B; Tsay HM; Turabi N; Mantha S; Yost F; Tu JI
Ther Drug Monit; 1992 Dec; 14(6):499-508. PubMed ID: 1485373
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
[TBL] [Abstract][Full Text] [Related]
33. 5-substituted arabinofuranosyluracil nucleosides: synthesis and antiviral properties.
Kulikowski T; Zawadzki Z; De Clercq E; Shugar D
Acta Biochim Pol; 1984; 31(3):341-56. PubMed ID: 6524217
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
[TBL] [Abstract][Full Text] [Related]
35. Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.
Harada K; Matulic-Adamic J; Price RW; Schinazi RF; Watanabe KA; Fox JJ
J Med Chem; 1987 Jan; 30(1):226-9. PubMed ID: 3027334
[TBL] [Abstract][Full Text] [Related]
36. Combined anti-herpes virus activity of nucleoside analogs and interferon.
Taylor JL; Punda-Polic V; O'Brien WJ
Curr Eye Res; 1991; 10 Suppl():205-11. PubMed ID: 1650669
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
38. 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
Griengl H; Wanek E; Schwarz W; Streicher W; Rosenwirth B; De Clercq E
J Med Chem; 1987 Jul; 30(7):1199-204. PubMed ID: 3037079
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides.
Rahim SG; Trivedi N; Bogunovic-Batchelor MV; Hardy GW; Mills G; Selway JW; Snowden W; Littler E; Coe PL; Basnak I; Whale RF; Walker RT
J Med Chem; 1996 Feb; 39(3):789-95. PubMed ID: 8576922
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
